LIVES™

The MaxLife Accelerator Fund utilizes the financial strategy known as LIVES™. This preferred strategy will finance the research needed to profitably develop life extending technologies. LIVES™ offers investors all of the following benefits:

  • Liquidity. Invested funds or “deposits” are redeemable, much like a bank CD.
  • Income. Depositors earn 6% projected annual dividends.
  • Venture capital returns. Depositors earn a projected annual internal rate of return (IRR) of 27% over the 10 year life of the fund plus residuals from the 11th–17th years.
  • Equity. Depositors get positions in potentially some of the world’s bigger and more profitable companies. The projected IRR does not reflect this potentiality.
  • Safety. Your deposits are never exposed to more than a 10% drawdown.

Compared with popular investment vehicles, LIVES™ not only shines in each illustrated category, but it also offers the potential to ultimately save up to 37 million lives per year.

Table 1. Investment Vehicle Comparisons

LIVES™
CMO’s
LIVES™ BondsS&P 500Hedge Funds20 Year T-BondsFuturesVenture Capital
LiquidityYesYesYesYesYesYesNo
IncomeYesYesNoNoYesNoNo
Predictable Cash FlowYesYesNoNoYesNoNo
Annual Return27%*
24%*11.3%*14.8***5.3%****6.3%*****21%
Largest Annual Drawdown<10%<5%64%**11.4%***13.3%****17.7%*****N/A

*Projected. Assumptions will be proven with documented personal presentation to your due diligence team.
**64% in 1932. 35% in 1937, 34% in 1974 and 40% in 2002
***Hedge Fund Research Index 1990-2005
****1926-1999
*****Managed Futures Index 1994-2005

Click here for information on the MaxLife Accelerator Fund

Back to Top

Funding Anti Aging Research | Life Extension Projects | Publications About Human Aging | Events to Reverse Aging | Longevity News